NABL, CAP, ISO
Overview of HLA B-27, Flowcytometry
What is HLA B-27, Flowcytometry?
This is a marker which is used to evaluate if you are suffering from certain auto immune disorders like ankylosing spondylitis, reactive arthritis or anterior uveitis.
Why is HLA B-27, Flowcytometry done?
- If you have acute or chronic pain and inflammation in the spine, neck, chest, eyes or joints and the doctor is suspecting an autoimmune disorder
- If you have recurrent uveitis
- If your doctor is suspecting that you are suffering from ankylosing spondylitis
Preparation for HLA B-27, Flowcytometry
- No special preparation required
Sample Type for HLA B-27, Flowcytometry
The sample type collected for HLA B-27, Flowcytometry is: Blood
Interpreting HLA B-27, Flowcytometry results
- Positive HLA B27 test along with features of chronic pain, inflammation, changes in bones as seen on X ray usually supports a diagnosis of ankylosing spondylitis, reactive arthritis or another auto immune disorder
- Negative HLA B27 test does not necessarily mean that you are not suffering from the suspected auto immune disorder since this marker is not positive in all patients
- The results of HLA B27 should always be correlated with patient’s history and radiologic findings
We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).